CASP1 and Hepatic steatosis: In agreement with the decreased hepatic inflammation observed in clodronate-treated mice, caspase-1-deficient mice (that lack IL-1β expression) exhibit attenuated diet-induced hepatic steatosis and significant decreases in hepatic lipogenic gene expression compared with wild type control mice [33].